Since PHB1 and PHB2 were reported to regulate ERα signaling, which is a central oncogenic pathway in luminal breast cancer, we focused on the implication of PGRMC1 in the ERα signaling network and its possible involvement in breast cancer promotion. The gene discussed is ESR1; the disease is breast carcinoma.